WTS (NYSE: WTS) holder files Rule 144 notice to sell 605 common shares
Rhea-AI Filing Summary
A holder of WTS common stock filed a notice under Rule 144 to sell 605 shares with an aggregate market value of 167451.90 through Morgan Stanley Smith Barney on the NYSE, with an approximate sale date of 12/17/2025.
The shares to be sold were originally issued as restricted stock by the issuer in multiple grants between 2022 and 2024. The notice states that the person for whose account the securities will be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. The issuer reports 27406631 common shares outstanding, providing context for the size of this proposed sale.
Positive
- None.
Negative
- None.
FAQ
What does the latest Rule 144 notice for WTS disclose?
The notice discloses that a holder of WTS common stock intends to sell 605 shares with an aggregate market value of 167451.90 through Morgan Stanley Smith Barney on the NYSE, with an approximate sale date of 12/17/2025.
How many WTS shares are planned to be sold and what is their market value?
The planned sale covers 605 shares of WTS common stock with an aggregate market value of 167451.90, as stated in the notice.
When and how were the WTS shares being sold under Rule 144 originally acquired?
The 605 shares were acquired as restricted stock from the issuer in several grants on dates including 03/15/2022, 03/15/2023, 03/16/2023, 03/12/2024, 03/13/2024, and 03/15/2024, with each grant fully paid on its acquisition date.
How many WTS common shares are outstanding according to this Rule 144 notice?
The notice reports that there are 27406631 shares of WTS common stock outstanding.
Which broker and exchange are involved in the planned WTS share sale?
The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are listed for trading on the NYSE.
Does the person filing the WTS Rule 144 notice claim to have undisclosed adverse information?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.